Discordant rifampicin susceptibility results are associated with Xpert(®) MTB/RIF probe B and probe binding delay

von Berhanu, R. H., Schnippel, K., Kularatne, R., Firnhaber, C., Jacobson, K. R., Horsburgh, C. R., Lippincott, C.K.
Veröffentlicht in Int J Tuberc Lung Dis (2019)

Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay

von Berhanu, R. H., Schnippel, K., Kularatne, R., Firnhaber, C., Jacobson, K. R., Horsburgh, C. R., Lippincott, C.K.
Veröffentlicht in Int J Tuberc Lung Dis (2019)

Overcoming limitations of tuberculosis information systems: researcher and clinician perspectives

von van der Heijden, Y. F., Hughes, J., Dowdy, D. W., Streicher, E., Chihota, V., Jacobson, K. R., Warren, R., Theron, G.
Veröffentlicht in Public Health Action (2019)

The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis

von Ragan, E. J., Kleinman, M. B., Sweigart, B., Gnatienko, N., Parry, C. D., Horsburgh, C. R., LaValley, M. P., Myers, B., Jacobson, K. R.
Veröffentlicht in Int J Tuberc Lung Dis (2020)

Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa

von Mukinda, F. K., Theron, D., van der Spuy, G. D., Jacobson, K. R., Roscher, M., Streicher, E. M., Musekiwa, A., Coetzee, G. J., Victor, T. C., Marais, B. J., Nachega, J. B., Warren, R. M., Schaaf, H. S.
Veröffentlicht 2012